The Rise of the  Climax Needle  in Mainland China: A Dangerous Frenzy of  Intelligence Tax  and Moral Marginalisation

The rise of the 'climax needle' in mainland China represents a dangerous frenzy surrounding the concepts of 'intelligence tax' and moral marginalisation. (Illustrative image, AI-generated)

[People News] In recent years, a medical beauty procedure known as the 'climax needle' has gained popularity in mainland China. This treatment claims to enhance sexual sensitivity and orgasm experiences by injecting substances such as platelet-rich plasma (PRP) or hyaluronic acid into women's intimate areas (like the G-spot and clitoris), thereby stimulating nerve and blood vessel regeneration. The cost of this procedure ranges from 6,000 to 30,000 yuan per injection, depending on the hospital's level, the qualifications of the doctor, and the type of substance used. Some female users have shared their experiences on platforms like Xiaohongshu, describing the 'climax needle' as a 'life-changing' enhancement to their sex lives. However, the medical community remains skeptical about its effectiveness, citing a lack of clinical evidence and potential risks such as infection and bruising. In 2024, the market for the climax needle in China is projected to reach 8.7 billion yuan, with expectations to surpass 15 billion yuan by 2025, indicating a significant commercial trend. Public opinion on this issue is divided; some view it as a form of 'self-pleasure consumption' for women, while others criticise it as a representation of 'intelligence tax' and moral decline.

The popularity of the climax needle in mainland China superficially reflects a consumer trend among women seeking sexual happiness and self-satisfaction, but it also highlights the complex interplay of various social and cultural factors, along with potential economic and moral risks.

Firstly, the awakening of women's 'self-pleasure consciousness' and its commercialisation are key driving forces. With the emergence of the 'she economy', Chinese women are increasingly prioritising their own needs, leading to a shift in sexual health and experiences from taboo subjects to open discussions. The climax needle specifically targets women aged 30-45, particularly those experiencing vaginal looseness or reduced sensitivity after childbirth, claiming to improve sexual quality and thus addressing a market gap. Medical beauty institutions create an alluring illusion of 'climax freedom' through extensive user testimonials on platforms like Xiaohongshu and Weibo (for example, claims of 'more harmonious couple relationships'), which attract female consumers. However, this commercial promotion often exaggerates the effects and lacks rigorous clinical data to support its claims, with actual results varying from person to person; some women report only a fleeting sensation of engorgement. The high costs (ranging from 6,000 to 30,000 yuan per injection) and the high repurchase rates (with effects lasting only 6-12 months) render it a typical 'intelligence tax', capitalising on women's desire for sexual fulfilment to generate profit.

Secondly, pathological aesthetics contribute to the problem. The 'white, thin, young' beauty standards prevalent in Chinese society, along with stereotypical expectations of women's sexual roles, objectify women as instruments for 'pleasing men'. The climax needle is marketed as a way for women to become 'tighter' and 'more sensitive', reinforcing this objectification and suggesting that women must alter their bodies to satisfy male desires. This 'male-pleasing' cultural packaging superficially presents itself as 'self-pleasing', but in reality, it conforms to distorted aesthetic standards. Some women are willing to risk injecting intimate areas in their pursuit of a 'perfect sexual experience'.

The rise of climax injections presents significant dangers to society. Firstly, this 'IQ tax' business model undermines women's economic interests. Medical beauty institutions attract consumers with high prices while failing to disclose potential risks, such as infections, bruising, or reduced sensitivity from long-term use. Small clinics, luring customers with low prices, further exacerbate safety concerns, as unqualified providers may lead to serious complications. By 2024, the market for climax injections has reached 8.7 billion yuan, with projections to exceed 15 billion yuan by 2025, highlighting the alarming scale of capital's exploitation of women's wealth.

A deeper issue is the erosion of moral standards. In the quest for pleasure, modern individuals have starkly commodified the intimate experience of sexual climax, treating it as a 'pleasure' that can be bought. The trend of climax injections reflects the extreme objectification of women's bodies and sexuality, driven by consumerism and hedonism, resulting in a diminished respect for intimate relationships and self-worth. This behaviour not only reinforces the stereotype of women as 'sexual tools' but also reduces sex to a mechanised commodity, weakening the emotional and ethical foundations. As women take risks to alter their intimate areas in pursuit of 'climax freedom', societal shame and moral boundaries are further challenged, promoting a distorted value system that elevates hedonism above all else.

The rise of the climax needle reflects a troubling intersection of consumerism and pathological aesthetics. While it superficially caters to women's desires for self-pleasure, it effectively acts as an 'intelligence tax' that siphons off wealth and exacerbates women's dissatisfaction with their bodies. Medical beauty institutions and capitalists take advantage of women's longing for sexual fulfilment, fabricating a deceptive narrative of 'climax freedom' that obscures the associated health risks and moral decline. In the relentless pursuit of pleasure, the fundamental boundaries of shame are disregarded, reducing women to mere sexual objects. Society must remain alert to this trend, promoting the idea that women should seek genuine self-worth through health and confidence, rather than falling prey to the forces of capitalism and hedonism. Regulatory bodies must enhance medical standards surrounding climax needles, rein in commercial excesses, safeguard women's rights, and maintain ethical standards. 

(Originally published by the People News)